Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 91 Print this page  Email this page Small font size Default font size Increase font size
CASE REPORT
Year : 2015  |  Volume : 30  |  Issue : 2  |  Page : 158-161

Missing sentinel lymph node in cutaneous melanoma


1 Department of Nuclear Medicine, A. O. Ospedale Civile di Legnano, Legnano; Nuclear Medicine Residency, University of Milan, Milano, Italy
2 Department of Nuclear Medicine, IRCCS Cà Grande Maggiore Policlinico Hospital Foundation, Milano, Italy
3 Department of Nuclear Medicine, A. O. Ospedale Civile di Legnano, Legnano, Italy

Correspondence Address:
Prof. Lorenzo Stefano Maffioli
Department of Nuclear Medicine, A. O. Ospedale Civile di Legnano, Via Papa Giovanni Paolo II, 1-20025 Legnano (MI)
Italy
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0972-3919.152982

Rights and Permissions

The American Society of Clinical Oncology guidelines recommend sentinel lymph node biopsy (SLNB) for all patients with melanoma tumors of intermediate thickness (between 1 and 4 mm). In case of patients with thick melanoma tumors (>4 mm), SLNB may be recommended as well, for staging purposes and to facilitate regional disease control. We report a case of an 82-year-old man, undergone excision of a cutaneous melanoma of the right thigh, which shows some limitation of SLNB in thick melanoma. Lymphoscintigraphy, performed as single-photon emission computed tomography/computed tomography (SPECT/CT), failed to identify the real sentinel lymph node, as tracer uptake was seen in A right inguinal node. Due to the presence on CT co-registered images of another suspicious node (with no radiopharmaceutical uptake) in the crural region, and considering the "high-risk" pathologic features of the removed primary lesion, a 18F-fluorodeoxyglucose positron emission tomography/CT (18F-FDG PET/CT) staging scan was planned. PET/CT showed high metabolic activity in the suspected crural lymphadenopathy. Histopathology demonstrated massive invasion of the crural ("sentinel") node and no metastatic cells in the inguinal node. This report highlights both the higher accuracy of lymphoscintigraphy, when performed as SPECT/CT and the potential utility of 18F-FDG PET/CT in regional staging.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed577    
    Printed23    
    Emailed0    
    PDF Downloaded63    
    Comments [Add]    

Recommend this journal